Stockscreener 앱 받기
4.42
0.90%
-0.04
Artiva Biotherapeutics Inc 주식(ARTV)의 최신 뉴스
Aug Catalysts: How do insiders feel about Artiva Biotherapeutics IncJuly 2025 Reactions & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Take Profit: Can Artiva Biotherapeutics Inc outperform in the next rallyWeekly Market Report & Daily Stock Trend Watchlist - baoquankhu1.vn
Wall Street Recap: Is AppTech Payments Corp Equity Warrant attractive for institutional investorsJuly 2025 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn
Trend Recap: Will Artiva Biotherapeutics Inc outperform its industry peers2025 Key Highlights & Accurate Intraday Trade Tips - baoquankhu1.vn
Artiva Biotherapeutics Stock: Upcoming Data Presentations In Focus (NASDAQ:ARTV) - Seeking Alpha
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Sees Significant Growth in Short Interest - MarketBeat
Published on: 2026-01-14 12:03:58 - baoquankhu1.vn
Quarterly Trades: Will Artiva Biotherapeutics Inc. stock gain from lower inflationWeekly Profit Recap & AI Powered Trade Plan Recommendations - Bộ Nội Vụ
Valuation Update: Can Pineapple Financial Inc be recession proofQuarterly Investment Review & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Published on: 2026-01-14 05:34:55 - baoquankhu1.vn
Sjogren’s Syndrome Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Astellas Pharma, Immunovant Sciences, NK Cells Artiva Biotherapeutics, Rise Therapeutics - Barchart.com
Bearish Setup: Will EWCZ stock benefit from green energy trends2025 Price Targets & Accurate Entry and Exit Point Alerts - Bộ Nội Vụ
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Artiva Biotherapeutics Reports Positive AlloNK Trial Results - MSN
Will Artiva Biotherapeutics Inc. stock gain from lower inflationJuly 2025 Review & Low Drawdown Investment Strategies - Улправда
How Artiva Biotherapeutics Inc. stock performs in weak economyQuarterly Market Summary & Technical Entry and Exit Tips - Улправда
Is Artiva Biotherapeutics Inc. stock oversold or undervaluedQuarterly Risk Review & Growth Focused Investment Plans - ulpravda.ru
Is Artiva Biotherapeutics Inc. stock a good choice for value investorsOil Prices & Stepwise Swing Trade Plans - Улправда
How Artiva Biotherapeutics Inc. stock performs in high volatility marketsJuly 2025 Sentiment & Proven Capital Preservation Methods - Улправда
NanoSyrinx Appoints New CEO to Advance Nanosyringe Technology - Intellectia AI
Artiva Biotherapeutics (NASDAQ:ARTV) Trading Up 4.3% – Should You Buy? - Defense World
Artiva Biotherapeutics expands board with industry veteran - MSN
Genelux Corporation Announces Appointment of Jason Litten as Chief Medical Officer, Effective January 2, 2026 - marketscreener.com
Artiva Biotherapeutics (ARTV): Evaluating Valuation After CEO’s Latest Insider Share Sale - Yahoo Finance
Will Artiva Biotherapeutics Inc. stock deliver long term returnsMarket Risk Summary & Reliable Entry Point Alerts - Улправда
Artiva Biotherapeutics Reports Increased Losses Amid Ongoing Development - MSN
Is Artiva Biotherapeutics Inc. stock undervalued vs historical averagesJuly 2025 PreEarnings & Technical Pattern Based Signals - DonanımHaber
Artiva Biotherapeutics, Inc.(NasdaqGM: ARTV) dropped from NASDAQ Biotechnology Index - marketscreener.com
CEO Moves: Can Artiva Biotherapeutics Inc. stock rebound after recent weakness2025 Big Picture & High Accuracy Swing Entry Alerts - Улправда
Can Artiva Biotherapeutics Inc. stock rebound after recent weaknessJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - Улправда
Resistance Check: Can Artiva Biotherapeutics Inc. stock rebound after recent weaknessDividend Hike & Free Safe Entry Trade Signal Reports - Улправда
ARTV Stock Price and Chart — NASDAQ:ARTV - TradingView — Track All Markets
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Artiva Biotherapeutics CEO sells $19,122 in stock By Investing.com - Investing.com Nigeria
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Artiva Biotherapeutics (ARTV) Stock: Today’s News (Dec. 16, 2025), Why Shares Spiked, Analyst Forecasts, and What Investors Are Watching Next - ts2.tech
Insider Sell: Fred Aslan Sells Shares of Artiva Biotherapeutics Inc (ARTV) - GuruFocus
Insider Selling: Artiva Biotherapeutics (NASDAQ:ARTV) CEO Sells 3,187 Shares of Stock - MarketBeat
Artiva Biotherapeutics CEO sells $19,122 in stock - Investing.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
US Stocks Mixed; NY Manufacturing Activity Dips In December - Benzinga
Wedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Artiva Biotherapeutics Executes RSU Exchange for Employees - TipRanks
Artiva Biotherapeutics Advances with Promising NK Cell Therapy Study - MSN
Artiva Biotherapeutics executes RSU exchange for employees - MSN
Pre Market Movers: XCUR, VOR, MTVA Set The Path - RTTNews
Analysts Are Bullish on Top Healthcare Stocks: CG Oncology, Inc. (CGON), Nurix Therapeutics (NRIX) - The Globe and Mail
How Artiva Biotherapeutics Inc. stock trades before earningsPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - Newser
Will Artiva Biotherapeutics Inc. stock outperform tech sector in 2025Trade Exit Report & Consistent Profit Trading Strategies - Newser
Risk Hedge: Can Artiva Biotherapeutics Inc. stock rebound after recent weakness2025 Institutional Moves & Daily Growth Stock Tips - Bộ Nội Vụ
A new trading data show Allarity Therapeutics Inc (ALLR) is showing positive returns. - Setenews
Analysts Set Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Target Price at $19.00 - Defense World
Artiva Biotherapeutics (ARTV) Stock Analysis Report | Financials & Insights - Benzinga
LNP | LancasterOnline Events3rd Cell Therapy for Autoimmune Disease Summit - LancasterOnline
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Artiva Biotherapeutics Inc. stock is seen as undervalued2025 Risk Factors & Reliable Momentum Entry Alerts - newser.com
Will Artiva Biotherapeutics Inc. stock beat EPS estimatesJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - newser.com
How resilient is Artiva Biotherapeutics Inc. stock in market downturnsWeekly Investment Report & Expert Curated Trade Ideas - newser.com
4.73%
0.92%
자본화:
|
볼륨(24시간):